- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Tropical Medicine
Volume 2012 (2012), Article ID 126093, 8 pages
Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
1Institute of Medicine, Tribhuvan University, Kathmandu 44168, Nepal
2KEM Hospital Research Center, Pune, Maharashtra 411011, India
3Umeå Center for Global Health Research, Umea University, 90187 Umeå, Sweden
4Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar 800007, India
5Institute of Medical Sciences, Banares Hindu University, Varanasi 221105, India
6International Center for Diarrheal Diseases Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
7BP Koirala Institute of Health Sciences, Dharan 56700, Nepal
8Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva, Switzerland
9Liverpool School of Tropical Medicine, Liverpool L35QA, UK
Received 20 December 2011; Accepted 21 February 2012
Academic Editor: Aditya Prasad Dash
Copyright © 2012 Megha Raj Banjara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. Mondal, S. P. Singh, N. Kumar et al., “Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy,” PLoS Neglected Tropical Diseases, vol. 3, no. 1, article no. e355, 2009.
- World Health Organization, Regional strategic framework for elimination of kala-azar from South East Asia region (2005-15), WHO SEAR, New Delhi, India, 2005.
- E. E. Zijlstra, A. M. Musa, E. A. G. Khalil, I. M. El Hassan, and A. M. El-Hassan, “Post-kala-azar dermal leishmaniasis,” The Lancet Infectious Diseases, vol. 3, no. 2, pp. 87–98, 2003.
- E. Hasker, S. P. Singh, P. Malaviya et al., “Management of visceral leishmaniasis in rural primary health care services in Bihar, India,” Tropical Medicine and International Health, vol. 15, no. 2, pp. 55–62, 2010.
- S. Hirve, S. P. Singh, N. Kumar et al., “Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal,” The American Journal of Tropical Medicine and Hygiene, vol. 83, no. 3, pp. 507–511, 2010.
- S. P. Singh, S. Hirve, M. M. Huda et al., “Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs,” PLoS Neglected Tropical Diseases, vol. 5, no. 2, article e960, 2011.
- World Health Organization, “Visceral Leishmaniasis Rapid Diagnostic Test performance,” Diagnostic evaluation series no.4. Special Program for Research and Training in Tropical Diseases, World Health Organization, 2011; p21, http://apps.who.int/tdr/svc/publications/tdr-research-publications/vl-rdt-evaluation.
- E. Rosenthal and P. Marty, “Recent understanding in the treatment of visceral leishmaniasis,” Journal of Postgraduate Medicine, vol. 49, no. 1, pp. 61–68, 2003.
- S. K. Bhattacharya, T. K. Jha, S. Sundar et al., “Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India,” Clinical Infectious Diseases, vol. 38, no. 2, pp. 217–221, 2004.
- S. Sundar, T. K. Jha, C. P. Thakur et al., “Oral miltefosine for Indian visceral leishmaniasis,” The New England Journal of Medicine, vol. 347, no. 22, pp. 1739–1746, 2002.
- S. Sundar, T. K. Jha, H. Sindermann, K. Junge, P. Bachmann, and J. Berman, “Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis,” Pediatric Infectious Disease Journal, vol. 22, no. 5, pp. 434–438, 2003.
- Govt. of India, “Guidelines on use of Miltefosine,” National Vector Borne Disease Control Program, Ministry of Health, Govt. of India, New Delhi. http://nvbdcp.gov.in/Doc/Guidelines%20on%20Miltefosine.pdf.
- Government of Nepal, Ministry of Health and Population, National strategic guideline on Kala-azar elimination program in Nepal 2009, Epidemiology and Disease Control Division, Teku, Nepal.
- Ministry of Health and Welfare Bangladesh, National strategic guideline on Kala-azar elimination program in Nepal 2009, Disease Control Unit, Directorate General of Health Services, Mohakhali, Bangladesh.
- J. E. Ware, M. K. Snyder, and W. R. Wright, “Development and validation of scales to measure patient satisfaction with medical care services. Vol I, Part A: Review of Literature, Overview of Methods and Results Regarding Construction of Scales,” (NTIS Publication No. PB 288-329), National Technical Information Service, Springfield, Va, USA.